Pure Global AI
Disease / condition

Lymphoma clinical trials

Free access to 719 studies10+ countriesUpdated daily51 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
719
Total trials
10+
Countries
10+
Sponsors
51
Recruiting
By phase
Phase 2318
N/A132
Phase 387
Phase 184
Early Phase 172
By status
Completed404
Unknown98
Terminated71
Recruiting51
Withdrawn35
Top countries
United States of America356
China55
United Kingdom28
France21
Canada,United States of America17
Top sponsors
M.D. Anderson Canc...63
Alliance for Clini...31
Memorial Sloan Ket...26
SWOG Cancer Resear...24
Northwestern Unive...18
Recent trials
Latest clinical trials for Lymphoma
AGMT Austrian Lymphoma Registry
Arbeitsgemeinschaft medikament... · Austria
NCT06294652Recruiting
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
M.D. Anderson Cancer Center · United States of America
NCT06218602Recruiting
Phase
Phase 2
CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study
Fondazione Policlinico Univers...
NCT06106776Not yet recr...
Navigating the Clinical Research Process for Lymphoma
Power Life Sciences Inc. · United States of America
NCT06070246Not yet recr...
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Hoffmann-La Roche · China,Italy,South Korea,Spain,Taiwan,United States of America
NCT06084936Recruiting
Phase
Phase 3
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
M.D. Anderson Cancer Center · United States of America
NCT06049134Recruiting
Phase
Phase 4
Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Chongqing University Cancer Ho... · China
NCT06026995Recruiting
Phase
Phase 4
A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers
Jiangsu HengRui Medicine Co., ... · China
NCT06010680Recruiting
Phase
Phase 1
Integrative Medicine in Lymphoma Survivors
Bnai Zion Medical Center · Israel
NCT05982223Recruiting
Zanubrutinib in Primary Cold Agglutinin Disease
Stichting Hemato-Oncologie voo... · Belgium,Denmark,Netherlands,Norway
NCT06067048Not yet recr...
Phase
Phase 2
CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma
Chinese PLA General Hospital · China
NCT05948033Recruiting
Phase
Phase 1/2
IVIG for Infection Prevention After CAR-T-Cell Therapy
Fred Hutchinson Cancer Center · United States of America
NCT05952804Not yet recr...
Phase
Phase 2
A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma
M.D. Anderson Cancer Center · United States of America
NCT05929612Recruiting
Phase
Phase 2
Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)
Immune Oncology Research Insti... · Armenia
NCT05891821Not yet recr...
Phase
Phase 2
the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma
Ou Bai, MD/PHD · China
NCT05834751Not yet recr...
Living Well With Lymphoma
University of Michigan Rogel C...
NCT06047626Not yet recr...
BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation
Rehab Werida · Egypt
NCT05813132Recruiting
First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228
Byondis B.V.
NCT05737628Not yet recr...
Phase
Phase 1
Expanded Access to Epcoritamab
AbbVie
NCT05692050No longer av...
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
M.D. Anderson Cancer Center · United States of America
NCT05683171Not yet recr...
Phase
Phase 1/2
View all 719 trials →
About this profile

Access comprehensive clinical trial information for Lymphoma through Pure Global AI's free database. This collection includes 719 clinical trials across multiple phases including Phase 2, N/A, Phase 3. Currently, 51 trials are actively recruiting participants.

Research for Lymphoma is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include M.D. Anderson Cancer Center and Alliance for Clinical Trials in Oncology. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 719 clinical trials studying Lymphoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include M.D. Anderson Cancer Center, Alliance for Clinical Trials in Oncology, Memorial Sloan Kettering Cancer Center, among others.